These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10202617)
21. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring. Sharma A; Shekhar C; Heer M; Minz M Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996 [TBL] [Abstract][Full Text] [Related]
22. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Morris RG; Russ GR; Cervelli MJ; Juneja R; McDonald SP; Mathew TH Ther Drug Monit; 2002 Aug; 24(4):479-86. PubMed ID: 12142630 [TBL] [Abstract][Full Text] [Related]
23. Neoral conversion from Sandimmune in maintenance renal transplant patients: an individualized approach. Curtis JJ; Lynn M; Jones PA J Am Soc Nephrol; 1998 Jul; 9(7):1293-300. PubMed ID: 9644641 [TBL] [Abstract][Full Text] [Related]
24. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation]. Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420 [TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group. Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802 [TBL] [Abstract][Full Text] [Related]
26. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients. Roth D; Miller J Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204 [No Abstract] [Full Text] [Related]
27. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients. Belitsky P; Dunn S; Johnston A; Levy G Clin Pharmacokinet; 2000 Aug; 39(2):117-25. PubMed ID: 10976658 [TBL] [Abstract][Full Text] [Related]
28. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Noble S; Markham A Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033 [TBL] [Abstract][Full Text] [Related]
29. Comparison of Neoral and Sandimmun cyclosporin A pharmacokinetic profiles in young renal transplant recipients. Kabasakul SC; Clarke M; Kane H; Karsten J; Clark G Pediatr Nephrol; 1997 Jun; 11(3):318-21. PubMed ID: 9203180 [TBL] [Abstract][Full Text] [Related]
30. A limited sampling strategy for the estimation of eight-hour neoral areas under the curve in renal transplantation. Meier-Kriesche HU; Kaplan B; Brannan P; Kahan BD; Portman RJ Ther Drug Monit; 1998 Aug; 20(4):401-7. PubMed ID: 9712465 [TBL] [Abstract][Full Text] [Related]
31. Microemulsion cyclosporin formulation, in contrast to the old formulation, widens the T lymphocyte subsets differences between stable and acute rejection of kidney transplants. Oliveira JG; Ramos JP; Xavier P; Sampaio S; Magalhães MC; Mendes AA; Pestana M Nephrol Dial Transplant; 2001 Jun; 16(6):1256-61. PubMed ID: 11390729 [TBL] [Abstract][Full Text] [Related]
32. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation. Bunnag S; Vareesangthip K; Ong-ajyooth L J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476 [TBL] [Abstract][Full Text] [Related]
33. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group. Pollard SG; Lear PA; Ready AR; Moore RH; Johnson RW Transplantation; 1999 Nov; 68(9):1325-31. PubMed ID: 10573071 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral. Melter M; Rodeck B; Kardorff R; Hoyer PF; Brodehl J Transpl Int; 1997; 10(6):419-25. PubMed ID: 9428114 [TBL] [Abstract][Full Text] [Related]
35. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group. Hoyer PF Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758 [TBL] [Abstract][Full Text] [Related]
36. NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation. Alvarez F; Atkison PR; Grant DR; Guilbault N; Jones AB; Kim PS; Kneteman NM; Laurin L; Martin SR; Murphy GF; Paradis K; Shapiro J; Smith LJ; Superina RA Transplantation; 2000 Jan; 69(1):87-92. PubMed ID: 10653385 [TBL] [Abstract][Full Text] [Related]
37. Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients. Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R Transplant Proc; 2003 Jun; 35(4):1300-3. PubMed ID: 12826143 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of the conventional and microemulsion formulations of cyclosporine in pancreas-kidney transplant recipients with gastroparesis. van der Pijl JW; Srivastava N; Denouël J; Burggraaf J; Schoemaker RC; van der Woude FJ; Cohen AF Transplantation; 1996 Aug; 62(4):456-62. PubMed ID: 8781610 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral. Wang CH; Ko WJ; Chou NK; Wang SS Transplant Proc; 2004 Oct; 36(8):2386-7. PubMed ID: 15561257 [TBL] [Abstract][Full Text] [Related]
40. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation. Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]